Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Current Assets (2016 - 2025)

Historic Current Assets for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $60.1 million.

  • Marimed's Current Assets rose 602.15% to $60.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.1 million, marking a year-over-year increase of 602.15%. This contributed to the annual value of $53.5 million for FY2024, which is 403.83% up from last year.
  • Per Marimed's latest filing, its Current Assets stood at $60.1 million for Q3 2025, which was up 602.15% from $57.1 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Current Assets ranged from a high of $60.1 million in Q3 2025 and a low of $31.7 million during Q1 2021
  • For the 5-year period, Marimed's Current Assets averaged around $50.1 million, with its median value being $53.1 million (2024).
  • As far as peak fluctuations go, Marimed's Current Assets surged by 21507.36% in 2021, and later plummeted by 1788.31% in 2022.
  • Over the past 5 years, Marimed's Current Assets (Quarter) stood at $44.6 million in 2021, then dropped by 1.05% to $44.1 million in 2022, then increased by 16.5% to $51.4 million in 2023, then grew by 4.04% to $53.5 million in 2024, then grew by 12.3% to $60.1 million in 2025.
  • Its Current Assets was $60.1 million in Q3 2025, compared to $57.1 million in Q2 2025 and $58.0 million in Q1 2025.